The Optomap system captures a digital image of approximately 80% of your retina. Utilizing its advanced Virtual Scan Point technology, it can acquire images in just 0.25 seconds. This results in a retinal image that seems as though it was captured from within the eye itself, providing detailed and comprehensive visualization for evaluation.
Prior to the development of advanced imaging technologies like the Optomap, traditional retinal cameras were limited to capturing images covering only about 45 degrees of the retina, which accounts for roughly 15% of its total area. These conventional systems were primarily restricted to imaging the posterior pole of the retina. To effectively visualize the peripheral regions, sophisticated technology capable of examining through varying pupil sizes was essential.
Eye care specialists utilize this advanced imaging technology to assess retinal conditions, including diabetic retinopathy and macular degeneration. Additionally, it enables precise measurement of choroidal nevi—pigmented lesions located at the back of the eye. Developed by the Scotland-based company Optos, this technology has benefited over 13 million users globally.
The Daytona Optomap utilizes a low-power, multi-laser ophthalmoscope to capture high-resolution digital scans of the retina. By employing red and green laser wavelengths, it generates detailed retinal images, allowing for the assessment of multiple retinal layers through advanced image filtering.
The Optomap utilizes an ellipsoidal mirror with two focal points. The first focal point directs laser light to precisely focus on the retina, while the second ensures proper alignment of the patient’s eye for accurate imaging.
Additionally, it enhances retinal imaging by utilizing two laser wavelengths, which magnify and separate different retinal structures into distinct color components, facilitating more accurate diagnosis.
The Optos Daytona utilizes green and red laser wavelengths to generate overlapping pseudo-colored retinal images. The green laser penetrates the retina, providing detailed visualization of the retina and anterior retinal pigment epithelium (RPE), while the red laser penetrates deeper, allowing for the assessment of the choroid and posterior RPE.
The blue laser wavelength is optionally utilized for fluorescein angiography, distinguishing it from the green and red lasers, which are integral to standard imaging.
The Optomap is highly beneficial for both children and adults due to its user-friendly design. This advanced technology ensures a seamless patient experience, with built-in light cues assisting in proper positioning for optimal imaging.
Once positioned correctly, the Optomap effortlessly captures retinal images with exceptional accuracy. The imaging process takes just two minutes, with actual retinal photographs being captured in less than a second.
After the images are captured, patients typically spend an additional minute with their doctor to receive an explanation of the results. Providing a clear explanation of these images not only enhances patient understanding but also fosters confidence in your care, positioning you as a knowledgeable expert in the treatment of retinal disorders.
The Optomap seamlessly integrates with Electronic Health Record (EHR) systems, allowing for the automatic transfer of patients’ retinal images into their medical files. Additionally, the EHR system facilitates the secure emailing of retinal images to patients for their personal records.
Prior to a Daytona Optomap examination, it is important to inform patients about the purpose and benefits of the procedure. This enhances their experience with the technology and fosters trust in your medical services, encouraging future referrals.
For eye care professionals, providing thorough training for staff on the use of the Optomap is crucial for delivering high-quality medical services. Comprehensive training typically lasts 2 hours, significantly enhancing the efficiency and effectiveness of your practice.
When offering retinal medical services with the Optomap Daytona, several key factors should be considered. It is important to evaluate your return on investment (ROI), determine the number of patients required to break even, and decide whether to purchase the equipment outright or opt for a leasing arrangement.
The Optos Daytona is a significant investment, with a purchase price reaching up to $85,000. However, the return on investment (ROI) is highly favorable, as it is projected to generate a profit of approximately $9,000.
Achieving such a profit is possible with strategic adjustments to your service delivery. Implementing a pre-test system that allows patients to capture their retinal images and receive an explanation from a doctor can significantly enhance patient satisfaction and efficiency. This can be achieved through an investment in a pre-test setup.
It is essential that your patients fully understand each step of the process. Take the time to guide them through the technical aspects and outline the associated costs. By doing so, you demonstrate a commitment to their well-being, showing that your focus is on providing care rather than simply generating profit.
Choroidal Nevus is formed by the accumulation of melanocytes in the choroid, which are typically benign in nature. Key characteristics of choroidal nevi include a slate gray color, slight elevation, and well-defined borders. These lesions are best visualized using red wavelength imaging, as their location within the choroid prevents them from being detected in green wavelength images.
Below are sample images of choroidal melanoma and choroidal nevus, captured using the Daytona Optomap system.
Chorioretinal atrophy is a pathological eye condition characterized by the degeneration of the choroid and retina due to damage. It involves the deterioration of the outer layers of the sensory retina, retinal pigment epithelium (RPE), and choriocapillaris. This condition arises when there is a lack of circulation in the choriocapillaris, leading to tissue damage.
Additional symptoms of chorioretinal atrophy include pigment clumping within and around the affected lesion. This often results from the migration of degraded retinal pigment epithelium (RPE) cells, which move into the inner layers of the retina.
The Daytona image of chorioretinal atrophy can be viewed from multiple angles. At the posterior pole, the choroid is visible, while at the periphery, the sclera gives the lesion a distinct bright yellow appearance.
For individuals with albinism or very light-colored fundi, the green laser offers superior penetration of the choroid, resulting in a clearer choroidal image compared to the red laser, where the image is often scattered by the sclera. The Optomap Daytona images clearly illustrate this difference.
Most conventional cameras offer a limited field of view, but the Daytona technology provides an ultra-wide view of the retina, allowing for more comprehensive imaging.
While conventional cameras capture images up to 45 degrees, the Optomap offers an expansive 200-degree field of view. This allows for clear visualization of peripheral lesions that are typically difficult to detect.
While not overly complex, the Optos Daytona serves as an effective tool for training staff on its use and application in patient care. It also provides patients with a straightforward experience, helping them better understand their conditions with ease.
For example, when patients view an Optomap of their eye during the examination, it provides a more tangible understanding of their condition. A diabetic patient who observes a retinal hemorrhage firsthand is likely to be more impacted and engaged in their care than simply being advised to regulate their blood sugar.
Optomap images may appear different from traditional diabetic retinopathy (DR) fundus photography. Due to the deep focus capability of the Optomap, structures that were previously invisible—such as floaters, eyelashes, lens opacities, and eyelids—become visible in the resulting images.
For comprehensive retinal evaluations, patients must still undergo a dilated binocular indirect ophthalmoscopy (BIO) examination. Even with the use of Optomap imaging, the BIO examination remains essential.
The Optos Daytona is designed to complement a dilated BIO examination. It is most beneficial for patients with specific critical conditions when assessing retinal issues. The Optomap imaging effectively captures a wide array of retinal conditions, including
The Optos Daytona digital image scanner represents a significant advancement in retinal imaging, outperforming conventional cameras. It delivers high-resolution images and can capture an ultra-wide field of view, up to 200 degrees, providing comprehensive retinal imaging.
Traditional cameras offer lower resolution and capture images with a field of view of up to 45 degrees. In contrast, eye care specialists utilize this advanced technology to diagnose and manage conditions such as diabetic retinopathy, macular degeneration, and hypertensive retinopathy.
